ESG More Cost-Effective Long Term Than Semaglutide ESG More Cost-Effective Long Term Than Semaglutide

Semaglutide is an effective treatment option for weight loss, but its cost-effectiveness over the long term compared with ESG needs to be considered.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news